Quixotic Pharma Private Limited, a active private limited company, was established on 29 November 2002 in Punjab, Punjab, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232PB2002PTC025609. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.74 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Sanjay Dhir (Director), Rajesh Biswanath Shrivastava (Director), Sanjeev Kumar (Director). Past directors included . Sudhakar, Satish Kumar, Sanjay Dhir. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 569 Industrial Areaphase Ix Mohali, Punjab, Punjab, 160062.
U24232PB2002PTC025609
025609
29 November 2002
₹2.00 M
₹0.74 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Quixotic Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Dhir | Director | 01 Feb 2018 | Current |
| Rajesh Biswanath Shrivastava | Director | 13 Aug 2019 | Current |
| Sanjeev Kumar | Director | 29 Nov 2002 | Current |
| Hitesh Popatlal Oswal | Director | 01 Feb 2018 | Current |
| Ashok Kumar Mishra | Additional Director | 06 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 23 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 23 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Quixotic Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.32% increase. The company also saw a substantial fall in profitability, with a 23.45% decrease in profit. The company's net worth Soared by an impressive increase of 24.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Quixotic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Quixotic Pharma has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Quixotic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quixotic Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Quixotic Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Quixotic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was completed.
The activity Ashok Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 06 Mar 2025 & has been associated with this company since 9 months 19 days . was completed.
The activity Rajesh Biswanath Shrivastava was appointed as a Director was appointed as a Director on 13 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
The activity Sanjay Dhir was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 7 years 10 months . was completed.
Progress on Hitesh Popatlal Oswal was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 7 years 10 months . was documented.
The CIN of Quixotic Pharma Private Limited is U24232PB2002PTC025609.
Quixotic Pharma Private Limited is headquartered at 569 Industrial Areaphase Ix Mohali, Punjab, Punjab, 160062.
Quixotic Pharma Private Limited was incorporated on 29 November 2002.
The current directors of Quixotic Pharma Private Limited are
The primary industry of Quixotic Pharma Private Limited is Trade.
Quixotic Pharma Private Limited is unlisted.
The authorized capital of Quixotic Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹0.74 M.
The compliance status of Quixotic Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX